Quick answers
- What is Klor-Con M?
- Klor-Con M is a brand name of Potassium chloride, a prescription medicine. The FDA NDC Directory lists 4 Klor-Con M products in 3 strengths and forms.
- Who makes Klor-Con M?
- Upsher Smith Labs holds the FDA application for Klor-Con M (ANDA074726, approved November 20, 1998). 1 other company (repackagers or distributors) also list Klor-Con M products.
- Is there a generic or store brand of Klor-Con M?
- Yes. The FDA NDC Directory lists 88 other products with the same active ingredients, strength and form as a Klor-Con M product, 88 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Klor-Con M?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 3 Klor-Con M strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Klor-Con M been recalled?
- No recall linked to Klor-Con M products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Klor-Con M is
Each Klor-Con M product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Potassium chloride · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| potassium chloride 1125 mg tablet, extended release (oral) | Klor-Con M | 4 products, 4 companies | DailyMed |
| potassium chloride 1500 mg tablet, extended release (oral) | Klor-Con M | 38 products, 22 companies | DailyMed |
| potassium chloride 750 mg tablet, extended release (oral) | Klor-Con M | 46 products, 24 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Potassium chloride →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA074726 | Upsher Smith Labs | November 20, 1998 | 4 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| potassium chloride 1125 mg tablet, extended release | Brand: Klor-Con M | $0.4824 per tablet |
| potassium chloride 1500 mg tablet, extended release | Brand: Klor-Con M | $0.1422 per tablet Generic of the same strength and form: $0.1437–$0.1935 per tablet |
| potassium chloride 750 mg tablet, extended release | Brand: Klor-Con M | $0.1327 per tablet Generic of the same strength and form: $0.0838–$0.1329 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Klor-Con M
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Klor-Con M products.
- Upsher-Smith Laboratories, LLC3 products
- Cardinal Health 107, LLC1 product
Recalls
No recall linked to Klor-Con M products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.